Your browser is no longer supported. Please, upgrade your browser.
Settings
IMUC ImmunoCellular Therapeutics, Ltd. daily Stock Chart
IMUC [NYSE]
ImmunoCellular Therapeutics, Ltd.
Index- P/E- EPS (ttm)-7.30 Insider Own0.20% Shs Outstand3.55M Perf Week-27.04%
Market Cap4.12M Forward P/E- EPS next Y- Insider Trans- Shs Float3.45M Perf Month-53.97%
Income-22.30M PEG- EPS next Q- Inst Own9.50% Short Float12.26% Perf Quarter-57.04%
Sales- P/S- EPS this Y-34.50% Inst Trans-2.32% Short Ratio5.11 Perf Half Y-58.63%
Book/sh0.13 P/B8.92 EPS next Y- ROA-129.30% Target Price5.00 Perf Year-86.51%
Cash/sh1.49 P/C0.78 EPS next 5Y- ROE-295.80% 52W Range1.15 - 11.96 Perf YTD-43.41%
Dividend- P/FCF- EPS past 5Y1.10% ROI- 52W High-90.30% Beta1.41
Dividend %- Quick Ratio3.30 Sales past 5Y- Gross Margin- 52W Low0.87% ATR0.12
Employees7 Current Ratio3.30 Sales Q/Q- Oper. Margin- RSI (14)19.27 Volatility11.50% 8.34%
OptionableNo Debt/Eq0.00 EPS Q/Q33.50% Profit Margin- Rel Volume0.33 Prev Close1.20
ShortableNo LT Debt/Eq0.00 EarningsMar 09 AMC Payout- Avg Volume82.76K Price1.16
Recom3.00 SMA20-36.45% SMA50-50.67% SMA200-64.07% Volume27,100 Change-3.33%
Nov-11-16Downgrade Maxim Group Buy → Hold
Aug-23-16Reiterated Maxim Group Buy $3 → $2
Mar-10-15Reiterated Maxim Group Buy $4 → $3
Jun-02-14Reiterated Maxim Group Buy $12 → $4
Dec-12-13Downgrade MLV & Co Buy → Hold $6 → $1.25
Mar-06-13Reiterated MLV & Co Buy $3.50 → $5
Sep-06-12Initiated Maxim Group Buy $18
May-19-17 11:59PM  IMPORTANT INVESTOR ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Reminds Investors with Losses to Contact the Firm Accesswire
06:00PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against ImmunoCellular Therapeutics, Ltd. IMUC GlobeNewswire
May-18-17 04:42PM  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Reminds Investors with Losses to Contact the Firm Accesswire
11:24AM  EQUITY ALERT: Levi & Korsinsky, LLP Notifies Shareholders of ImmunoCellular Therapeutics, Ltd. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 30, 2017 - IMUC Accesswire
May-17-17 04:21PM  EQUITY ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Encourages Investors with Losses to Contact the Firm Accesswire
08:38AM  IMUC INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving ImmunoCellular Therapeutics, Ltd. and a Lead Plaintiff Deadline of June 30, 2017 Accesswire
May-16-17 08:21PM  IMMUNOCELLULAR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 in ImmunoCellular Therapeutics, Ltd. to Contact the Firm Business Wire -23.27%
01:45PM  EQUITY ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Encourages Investors with Losses to Contact the Firm Accesswire
10:08AM  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of ImmunoCellular Therapeutics, Ltd. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 30, 2017 - IMUC Accesswire
May-15-17 07:08PM  Lifshitz & Miller LLP Announces Investigation of Anadarko Petroleum Corporation, DryShips Inc., ImmunoCellular Therapeutics, Ltd., KBR, Inc., Sunesis Pharmaceuticals, Inc., Sunrun Inc. and Vince Holding Corp. PR Newswire
05:30PM  Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit has been Filed against ImmunoCellular Therapeutics, Ltd. (IMUC) and Encourages Investors to Contact the Firm Accesswire
04:23PM  SHAREHOLDER ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Encourages Investors with Losses to Contact the Firm Accesswire
04:05PM  ImmunoCellular Therapeutics Announces First Quarter 2017 Financial Results PR Newswire
08:48AM  IMUC SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving ImmunoCellular Therapeutics, Ltd. and a Lead Plaintiff Deadline of June 30, 2017 Accesswire
May-12-17 11:56PM  INVESTOR ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Encourages Investors with Losses to Contact the Firm Accesswire
04:00PM  IMPORTANT IMMUNOCELLULAR THERAPEUTICS, LTD. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Central District of California against ImmunoCellular Therapeutics, Ltd. GlobeNewswire
May-11-17 02:55PM  INVESTOR ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Encourages Investors with Losses to Contact the Firm Accesswire
08:45AM  IMUC EQUITY ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving ImmunoCellular Therapeutics, Ltd. and a Lead Plaintiff Deadline of June 30, 2017 Business Wire
May-10-17 06:12PM  SHAREHOLDER ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Encourages Investors with Losses to Contact the Firm Accesswire
05:45PM  IMUC LOSS NOTICE: Rosen Law Firm Reminds ImmunoCellular Therapeutics, Ltd. of Important Deadline in Class Action IMUC Business Wire
03:38PM  IMPORTANT EQUITY ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Encourages Investors with Losses to Contact the Firm PR Newswire
01:35PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of ImmunoCellular Therapeutics, Ltd. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 30, 2017 - IMUC Accesswire
May-09-17 05:28PM  IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Encourages Investors with Losses to Contact the Firm GlobeNewswire
12:02PM  EQUITY ALERT: Levi & Korsinsky, LLP Notifies Shareholders of ImmunoCellular Therapeutics, Ltd. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 30, 2017 - IMUC PR Newswire
May-08-17 04:25PM  IMPORTANT INVESTOR ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Encourages Investors with Losses to Contact the Firm GlobeNewswire
04:02PM  IMMUNOCELLULAR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In ImmunoCellular Therapeutics, Ltd. To Contact The Firm GlobeNewswire
02:06PM  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Encourages Investors with Losses to Contact the Firm PR Newswire
12:20PM  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of ImmunoCellular Therapeutics, Ltd. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 30, 2017 IMUC Business Wire
May-05-17 01:23PM  SHAREHOLDER NOTICE: Goldberg Law PC Announces the Filing of a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. PR Newswire -11.76%
10:32AM  The Klein Law Firm Announces a Class Action Filed on Behalf of ImmunoCellular Therapeutics, Ltd. Shareholders and a Lead Plaintiff Deadline of June 30, 2017 GlobeNewswire
May-04-17 08:32PM  IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Encourages Investors with Losses to Contact the Firm Accesswire -14.22%
08:00PM  Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against ImmunoCellular Therapeutics, Ltd. (IMUC) GlobeNewswire
06:19PM  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Encourages Investors with Losses to Contact the Firm Business Wire
04:58PM  Glancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of ImmunoCellular Therapeutics, Ltd. Investors and Encourages Investors to Contact the Firm Business Wire
10:08AM  IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Encourages Investors with Losses to Contact the Firm Business Wire
May-03-17 07:06PM  Robbins Arroyo LLP: ImmunoCellular Therapeutics, Ltd. (IMUC) Misled Shareholders According to a Recently Filed Class Action Business Wire
04:17PM  INVESTOR ALERT: Goldberg Law PC Announces the Filing of a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. Business Wire
03:32PM  IMUC SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving ImmunoCellular Therapeutics, Ltd. and a Lead Plaintiff Deadline of June 30, 2017 GlobeNewswire
10:52AM  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Encourages Investors with Losses to Contact the Firm Business Wire
May-02-17 10:14PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against ImmunoCellular Therapeutics, Ltd. IMUC Business Wire
03:40PM  IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against ImmunoCellular Therapeutics, Ltd. and Encourages Investors With Losses to Contact the Firm Business Wire
02:08PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notified Investors of Class Action Against ImmunoCellular Therapeutics, Ltd. (IMUC) and Lead Plaintiff Deadline - June 30, 2017 PR Newswire
11:48AM  SHAREHOLDER ALERT: Goldberg Law PC Announces the Filing of a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. Business Wire
10:07AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of ImmunoCellular Therapeutics, Ltd. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 30, 2017 IMUC GlobeNewswire
May-01-17 06:58PM  IMMUNOCELLULAR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In ImmunoCellular Therapeutics, Ltd. To Contact The Firm PR Newswire
04:15PM  Wolf Popper LLP Files Class Action Lawsuit Against ImmunoCellular Therapeutics, Ltd. GlobeNewswire
Mar-23-17 06:00AM  ImmunoCellular Therapeutics and Memgen Announce Letter of Intent for Potential Joint Immuno-Oncology Collaboration PR Newswire +9.35%
Mar-15-17 01:04PM  IMMUNOCELLULAR THERAPEUTICS, LTD. Financials
Mar-14-17 04:05PM  ImmunoCellular Therapeutics Receives Audit Opinion With Going Concern Explanation PR Newswire
Mar-10-17 04:13PM  Edited Transcript of IMUC earnings conference call or presentation 9-Mar-17 10:00pm GMT Thomson Reuters StreetEvents
Mar-09-17 04:18PM  IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statem
04:05PM  ImmunoCellular Therapeutics Announces Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update PR Newswire
07:07AM  Q4 2016 ImmunoCellular Therapeutics Ltd Earnings Release - After Market Close
Mar-06-17 04:05PM  ImmunoCellular Therapeutics to Report Fourth Quarter and Full Year 2016 Financial Results on March 9, 2017 PR Newswire
06:00AM  ImmunoCellular Therapeutics Provides Update on ICT-107 Phase 3 Glioblastoma Trial and Announces Advances in Stem-to-T-Cell Research Program PR Newswire
Jan-12-17 09:30AM  Latest Reports on ImmunoCellular Therapeutics and Neuralstem as Biotech Industry Scrutiny Grows after President Trump's Comments Accesswire
Dec-14-16 05:04PM  IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financ -6.93%
04:05PM  ImmunoCellular Therapeutics Announces Management Changes PR Newswire
Nov-21-16 07:03AM  Splits Calendar: ImmunoCellular Therapeutics splits before market open today (1:40 ratio) +25.95%
06:00AM  ImmunoCellular Therapeutics Reports Updated Immune Monitoring Data from ICT-107 Phase 2 Trial in Newly Diagnosed Glioblastoma at the Society for Neuro-Oncology Annual Meeting 2016 PR Newswire
Nov-18-16 05:17PM  IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year -6.56%
Nov-16-16 11:56AM  Reverse Splits Don't Leave a Lasting Impression at The Wall Street Journal -15.05%
06:00AM  ImmunoCellular Therapeutics Announces One-for-Forty Reverse Stock Split PR Newswire
Nov-14-16 04:42AM  Edited Transcript of IMUC earnings conference call or presentation 10-Nov-16 10:00pm GMT
Nov-11-16 08:08AM  ImmunoCellular Therapeutics downgraded by Maxim Group -10.79%
Nov-10-16 04:17PM  IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statem +7.26%
04:05PM  ImmunoCellular Therapeutics Announces Third Quarter 2016 Financial Results and Provides Research and Development Update PR Newswire
Nov-04-16 01:15PM  IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Nov-02-16 06:00AM  ImmunoCellular Therapeutics to Report Third Quarter 2016 Financial Results on November 10, 2016 PR Newswire
Sep-22-16 04:14PM  Cryoport and Database Integrations Launch Integrated Solution to Manage Patient and Manufacturer Schedules at Every Stage of the Clinical Trial Logistics Process PR Newswire
Sep-16-16 01:44PM  IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 8-K, Change in Directors or Principal Officers
Sep-13-16 09:43AM  5 Biotech Stocks That Are Broker Favorites
Sep-01-16 04:49PM  IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing R -15.03%
Aug-31-16 09:15AM  Latest Report on ImmunoCellular Therapeutics Post Earnings +21.33%
Aug-23-16 11:55AM  Edited Transcript of IMUC earnings conference call or presentation 22-Aug-16 9:00pm GMT
Aug-22-16 04:32PM  IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statem +5.18%
04:08PM  IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 10-Q, Quarterly Report
04:05PM  ImmunoCellular Therapeutics Announces Second Quarter 2016 Financial Results PR Newswire
Aug-17-16 06:00AM  ImmunoCellular Therapeutics to Report Second Quarter 2016 Financial Results on August 22, 2016 PR Newswire
Aug-09-16 08:45AM  ImmunoCellular Therapeutics Announces Pricing of $7.4 Million Public Offering PR Newswire -32.38%
Jul-25-16 06:00AM  ImmunoCellular Therapeutics Reports Progress in Two Lead Cancer Immunotherapy Programs PR Newswire
Jun-21-16 04:16PM  IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Jun-07-16 04:03PM  IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 8-K, Other Events +10.13%
06:00AM  ImmunoCellular Therapeutics Treats First Patient in ICT-107 Phase 3 Registrational Trial in Newly Diagnosed Glioblastoma PR Newswire
May-23-16 06:00AM  ImmunoCellular Therapeutics to Present at Marcum MicroCap Conference on June 2, 2016 PR Newswire
May-19-16 06:00AM  BioLife Solutions and MNX Global Logistics Partner to Support ImmunoCellular Therapeutics with Cold Chain Logistics in ICT-107 Phase 3 Clinical Trial in Glioblastoma PR Newswire
May-13-16 05:12PM  IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 10-Q, Quarterly Report -6.83%
May-12-16 04:40PM  IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statem -6.29%
04:10PM  ImmunoCellular Therapeutics Announces First Quarter 2016 Financial Results PR Newswire
May-09-16 03:45PM  CYRX: More Shots on Goal from New Accounts, New Capabilities Zacks Small Cap Research
May-06-16 06:00AM  ImmunoCellular Therapeutics Receives Regulatory Approval in Canada, the UK and the Netherlands to Initiate ICT-107 Phase 3 Trial in Newly Diagnosed Glioblastoma PR Newswire
May-04-16 06:00AM  ImmunoCellular Therapeutics to Report First Quarter 2016 Financial Results on May 12, 2016 PR Newswire
Mar-31-16 12:31PM  Edited Transcript of IMUC earnings conference call or presentation 30-Mar-16 9:00pm GMT
Mar-30-16 04:41PM  IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statem +6.37%
04:15PM  ImmunoCellular Therapeutics Announces 2015 Financial Results PR Newswire
Mar-29-16 06:11AM  ImmunoCellular Therapeutics to Report 2015 Financial Results on March 30, 2016 at noodls -6.46%
06:00AM  ImmunoCellular Therapeutics to Report 2015 Financial Results on March 30, 2016 PR Newswire
Mar-07-16 06:00AM  ImmunoCellular Therapeutics to Present at ROTH Conference on March 16, 2016 PR Newswire +10.54%
Mar-03-16 08:00AM  Cryoport Supports ImmunoCellular Therapeutics' 120-Site Phase III Clinical Trial With Cold Chain Logistics PR Newswire
Mar-02-16 04:24PM  IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 8-K, Change in Directors or Principal Officers
ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company, develops immune-based therapies for the treatment of various cancers. Its lead product candidate is ICT-107, a dendritic cell (DC) immunotherapy targeting cancer stem cells (CSCs) and cancer antigens, which is in Phase III clinical trials for the treatment of glioblastoma multiforme (GBM). The company is also developing ICT-140, a DC-based immunotherapy targeting CSCs and cancer antigens that is in Phase I clinical trials for the treatment of ovarian cancer; and ICT-121, a DC-based immunotherapy targeting CD133 markers and CSCs, which is in Phase I clinical trials to treat recurrent GBM and other solid tumor cancers. In addition, it has a portfolio of other potential therapeutic immunotherapies to treat cancer. The company was formerly known as Optical Molecular Imaging, Inc. and changed its name to ImmunoCellular Therapeutics, Ltd. in November 2006. ImmunoCellular Therapeutics, Ltd. is based in Calabasas, California.